Physician profile
William Marshall
NPI 1750731998
$11,130.09
in general payments reported to CMS, 2019-2025
14 companies · $544 in 2025
The $544 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,721 · 2020: $32.63 · 2021: $1,688 · 2022: $1,545 · 2023: $234 · 2024: $2,365 · 2025: $544.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,395 · Food and Beverage: $749.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,395.19 |
| Food and Beverage | $748.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medacta USA, INC. | $2,365.42 | 2024 | |
| Stryker Corporation | $2,308.46 | 2021-2025 | Mako |
| Peerless Surgical INC. | $1,987.07 | 2019 | |
| Skeletal Dynamics INC | $1,500.00 | 2019 | |
| Zimmer Biomet Holdings, INC. | $1,233.61 | 2019 | |
| Smith+Nephew, INC. | $1,215.28 | 2021-2022 | |
| Depuy Synthes Sales INC. | $178.07 | 2020-2023 | Orthovisc, Monovisc |
| Microport Orthopedics INC | $128.53 | 2021 | |
| Johnson & Johnson Health Care Systems INC. | $123.67 | 2022 | |
| Sanofi-Aventis U.S. LLC | $26.95 | 2023 | |
| Radius Health, INC. | $17.12 | 2022 | |
| Bioventus LLC | $15.81 | 2022 | |
| Avanos Medical | $15.28 | 2022 | |
| Kci USA, INC. | $14.82 | 2023 | Prevena Restor Arthroform |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Marshall listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.